Which statin adverse effect is rare but serious?

Enhance your knowledge of antihyperlipidemics and lipid management. Study with multiple choice questions and detailed explanations. Ace your test!

Rhabdomyolysis is the rare but serious adverse effect associated with statins. It’s uncommon overall, but the consequences are severe when it occurs because muscle breakdown releases myoglobin into the bloodstream, which can damage the kidneys and lead to acute kidney injury and electrolyte disturbances. This risk rises with higher statin doses, drug interactions that raise statin levels (such as certain antibiotics, fibrates, cyclosporine, or grapefruit juice), genetic factors affecting hepatic uptake, as well as factors like older age, kidney disease, or hypothyroidism. Clinically, you’d expect intense muscle pain and weakness, sometimes with dark urine, and labs showing a markedly elevated creatine kinase along with possible kidney function changes. The appropriate response is to stop the statin immediately, check CK and kidney tests, and initiate aggressive hydration and monitoring; more severe cases may require further medical interventions. In contrast, myalgias, mild transaminase elevations, or headaches are far more common and usually reversible, making rhabdomyolysis the standout rare but serious risk.